Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mycobacterium tuberculosis | 3-dehydroquinate dehydratase AroD (AROQ) (3-dehydroquinase) (type II dhqase) | Curated by TDR Targets | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Mycobacterium leprae | 3-dehydroquinate dehydratase AroD (AroQ) (3-dehydroquinase) (Type II DHQase) | Get druggable targets OG5_132746 | All targets in OG5_132746 |
Mycobacterium tuberculosis | 3-dehydroquinate dehydratase AroD (AROQ) (3-dehydroquinase) (type II dhqase) | Get druggable targets OG5_132746 | All targets in OG5_132746 |
Mycobacterium ulcerans | 3-dehydroquinate dehydratase | Get druggable targets OG5_132746 | All targets in OG5_132746 |
Candida albicans | 3-dehydroquinase | Get druggable targets OG5_132746 | All targets in OG5_132746 |
Candida albicans | 3-dehydroquinate dehydratase | Get druggable targets OG5_132746 | All targets in OG5_132746 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Possible alanine rich transferase | 3-dehydroquinate dehydratase AroD (AROQ) (3-dehydroquinase) (type II dhqase) | 147 aa | 148 aa | 26.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | cyclins | 0.0532 | 0.1509 | 0.149 |
Trypanosoma cruzi | cyclin, putative | 0.0994 | 0.4599 | 1 |
Trichomonas vaginalis | cyclins, putative | 0.0532 | 0.1509 | 0.3249 |
Trichomonas vaginalis | cyclin B, putative | 0.0994 | 0.4599 | 1 |
Echinococcus multilocularis | cyclins | 0.0532 | 0.1509 | 0.149 |
Toxoplasma gondii | hypothetical protein | 0.0404 | 0.0649 | 1 |
Echinococcus granulosus | cyclins | 0.0532 | 0.1509 | 0.149 |
Trichomonas vaginalis | cyclins, putative | 0.0994 | 0.4599 | 1 |
Trichomonas vaginalis | cyclin B, putative | 0.0994 | 0.4599 | 1 |
Leishmania major | CYC2-like cyclin, putative,cyclin 6, putative | 0.0994 | 0.4599 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0532 | 0.1509 | 0.3249 |
Echinococcus granulosus | cyclins | 0.0532 | 0.1509 | 0.149 |
Trichomonas vaginalis | cyclin B, putative | 0.0532 | 0.1509 | 0.3249 |
Loa Loa (eye worm) | hypothetical protein | 0.0994 | 0.4599 | 0.4599 |
Trichomonas vaginalis | cyclin B, putative | 0.0994 | 0.4599 | 1 |
Entamoeba histolytica | cyclin family protein | 0.0532 | 0.1509 | 0.3249 |
Trichomonas vaginalis | cyclins, putative | 0.0994 | 0.4599 | 1 |
Schistosoma mansoni | cyclins | 0.0532 | 0.1509 | 0.149 |
Trichomonas vaginalis | cyclins, putative | 0.059 | 0.1895 | 0.4093 |
Echinococcus multilocularis | cyclins | 0.0532 | 0.1509 | 0.149 |
Mycobacterium leprae | 3-dehydroquinate dehydratase AroD (AroQ) (3-dehydroquinase) (Type II DHQase) | 0.1429 | 0.7507 | 0.5 |
Trypanosoma brucei | mitotic cyclin 6 | 0.0994 | 0.4599 | 1 |
Echinococcus granulosus | cyclin B3 1 | 0.0532 | 0.1509 | 0.149 |
Echinococcus granulosus | cyclins | 0.0532 | 0.1509 | 0.149 |
Trypanosoma cruzi | cyclin 6, putative | 0.0994 | 0.4599 | 1 |
Mycobacterium tuberculosis | 3-dehydroquinate dehydratase AroD (AROQ) (3-dehydroquinase) (type II dhqase) | 0.1429 | 0.7507 | 0.5 |
Loa Loa (eye worm) | cyclin domain-containing protein | 0.1801 | 1 | 1 |
Schistosoma mansoni | cyclin B3 | 0.1801 | 1 | 1 |
Echinococcus multilocularis | cyclin b3 | 0.0532 | 0.1509 | 0.149 |
Echinococcus granulosus | cyclins | 0.0532 | 0.1509 | 0.149 |
Loa Loa (eye worm) | CMGC/CDK/CDC2 protein kinase | 0.031 | 0.0022 | 0.0022 |
Echinococcus granulosus | G2:mitotic specific cyclin B3 | 0.1801 | 1 | 1 |
Giardia lamblia | G2/mitotic-specific cyclin B | 0.0994 | 0.4599 | 1 |
Plasmodium falciparum | cyclin | 0.0532 | 0.1509 | 1 |
Entamoeba histolytica | cyclin, putative | 0.0994 | 0.4599 | 1 |
Echinococcus multilocularis | cyclins | 0.0532 | 0.1509 | 0.149 |
Echinococcus multilocularis | cyclin B3 1 | 0.0532 | 0.1509 | 0.149 |
Loa Loa (eye worm) | hypothetical protein | 0.0994 | 0.4599 | 0.4599 |
Loa Loa (eye worm) | hypothetical protein | 0.0462 | 0.1036 | 0.1036 |
Trypanosoma cruzi | CYC2-like cyclin, putative | 0.0994 | 0.4599 | 1 |
Loa Loa (eye worm) | CMGC/CDK/CDC2 protein kinase | 0.031 | 0.0022 | 0.0022 |
Echinococcus multilocularis | cyclins | 0.0532 | 0.1509 | 0.149 |
Echinococcus granulosus | cyclin B | 0.0994 | 0.4599 | 0.4587 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0994 | 0.4599 | 0.4587 |
Trichomonas vaginalis | cyclin D, putative | 0.0532 | 0.1509 | 0.3249 |
Entamoeba histolytica | cyclin, putative | 0.0532 | 0.1509 | 0.3249 |
Echinococcus multilocularis | Zinc finger, DBF type | 0.0442 | 0.0902 | 0.0882 |
Giardia lamblia | Hypothetical protein | 0.0532 | 0.1509 | 0.3249 |
Trichomonas vaginalis | cyclin D, putative | 0.0532 | 0.1509 | 0.3249 |
Echinococcus multilocularis | cyclin B | 0.0994 | 0.4599 | 0.4587 |
Echinococcus granulosus | cyclin b3 | 0.0532 | 0.1509 | 0.149 |
Entamoeba histolytica | cyclin family protein | 0.0532 | 0.1509 | 0.3249 |
Onchocerca volvulus | 0.0994 | 0.4599 | 0.5 | |
Trichomonas vaginalis | cyclins, putative | 0.0994 | 0.4599 | 1 |
Giardia lamblia | Cyclin A | 0.0532 | 0.1509 | 0.3249 |
Schistosoma mansoni | hypothetical protein | 0.0442 | 0.0902 | 0.0882 |
Trichomonas vaginalis | cyclin A, putative | 0.0994 | 0.4599 | 1 |
Trichomonas vaginalis | cyclin B3, putative | 0.0532 | 0.1509 | 0.3249 |
Trichomonas vaginalis | cyclins, putative | 0.0994 | 0.4599 | 1 |
Echinococcus multilocularis | G2:mitotic specific cyclin B3 | 0.1801 | 1 | 1 |
Schistosoma mansoni | cyclin B | 0.0994 | 0.4599 | 0.4587 |
Loa Loa (eye worm) | CMGC/CDK/CDK5 protein kinase | 0.031 | 0.0022 | 0.0022 |
Plasmodium vivax | protein kinase Crk2 | 0.031 | 0.0022 | 0.5 |
Echinococcus multilocularis | cyclins | 0.0532 | 0.1509 | 0.149 |
Trypanosoma cruzi | cyclin, putative | 0.0994 | 0.4599 | 1 |
Leishmania major | cyclin | 0.0994 | 0.4599 | 1 |
Echinococcus multilocularis | cyclins | 0.0532 | 0.1509 | 0.149 |
Echinococcus granulosus | cyclins | 0.0532 | 0.1509 | 0.149 |
Mycobacterium ulcerans | 3-dehydroquinate dehydratase | 0.1429 | 0.7507 | 0.5 |
Trichomonas vaginalis | cyclin B, putative | 0.0994 | 0.4599 | 1 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0994 | 0.4599 | 0.4587 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 5 % | Cell cycle perturbations in mouse L1210 cells assessed as accumulation in G1 phase after 21 hrs at 5 uM relative to control | ChEMBL. | 16279796 |
Activity (functional) | = 5 % | Cell cycle perturbations in mouse L1210 cells assessed as accumulation in G1 phase after 21 hrs at 5 uM relative to control | ChEMBL. | 16279796 |
Activity (functional) | = 7 % | Cell cycle perturbations in mouse L1210 cells assessed as accumulation in S phase after 21 hrs at 5 uM relative to control | ChEMBL. | 16279796 |
Activity (functional) | = 7 % | Cell cycle perturbations in mouse L1210 cells assessed as accumulation in S phase after 21 hrs at 5 uM relative to control | ChEMBL. | 16279796 |
Activity (functional) | = 17 % | Cell cycle perturbations in mouse L1210 cells assessed as accumulation in G2+M phase after 21 hrs at 5 uM relative to control | ChEMBL. | 16279796 |
Activity (functional) | = 17 % | Cell cycle perturbations in mouse L1210 cells assessed as accumulation in G2+M phase after 21 hrs at 5 uM relative to control | ChEMBL. | 16279796 |
Activity (functional) | = 71 % | Cell cycle perturbations in mouse L1210 cells assessed as accumulation in 8N phase after 21 hrs at 5 uM relative to control | ChEMBL. | 16279796 |
Activity (functional) | = 71 % | Cell cycle perturbations in mouse L1210 cells assessed as accumulation in 8N phase after 21 hrs at 5 uM relative to control | ChEMBL. | 16279796 |
IC50 (functional) | = 1.5 uM | Antiproliferative activity against mouse L1210 cells after 48 hrs relative control | ChEMBL. | 16279796 |
IC50 (functional) | = 1.5 uM | Antiproliferative activity against mouse L1210 cells after 48 hrs relative control | ChEMBL. | 16279796 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Mus musculus | ChEMBL23 | 16279796 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.